However, the abnormal activation of proto-oncogenes such as Met or Src, which is observed in cancer cells, leads to the phosphorylation of tyrosine residues in the conserved domain in the cytoplasmic tail of E-cadherin, resulting in ubiquitin-dependent degradation of this molecule [3]. The gene discussed is CDH1; the disease is cancer.